Literature DB >> 830205

Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.

T D Sellers, R W Campbell, T M Bashore, J J Gallagher.   

Abstract

Thirty-three patients with Wolff-Parkinson-White syndrome were studied electrophysiologically before and after administration of intravenous procainamide and oral quinidine sulfate. Procainamide prolonged the shortest R-R (SRR) interval between two consecutive pre-excited beats during atrial fibrillation 20-70 msec in 15 of 21 patients with no change observed in 6 of 21 patients. Quinidine sulfate prolonged the SRR 20-170 msec in all 16. In 14 of 18 patients where procainamide and quinidine were comparable, quinidine prolonged the SRR 30-100 msec more than procainamide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830205     DOI: 10.1161/01.cir.55.1.15

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Medical staff conference. Treatment of cardiac arrhythmias.

Authors: 
Journal:  West J Med       Date:  1979-12

2.  Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

Authors:  Demosthenes G Katritsis; Giuseppe Boriani; Francisco G Cosio; Pierre Jais; Gerhard Hindricks; Mark E Josephson; Roberto Keegan; Bradley P Knight; Karl-Heinz Kuck; Deirdre A Lane; Gregory Yh Lip; Helena Malmborg; Hakan Oral; Carlo Pappone; Sakis Themistoclakis; Kathryn A Wood; Kim Young-Hoon; Carina Blomström Lundqvist
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

3.  Acute prolongation of myocardial refractoriness by sotalol.

Authors:  D H Bennett
Journal:  Br Heart J       Date:  1982-06

Review 4.  The electrocardiogram in the assessment of the effect of drugs on cardiac arrhythmias.

Authors:  D S Reid
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

5.  Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.

Authors:  Jinzhu Hu; Jianhua Yu; Qi Chen; Jianxin Hu; Qianghui Huang; Zhen Xia; Zirong Xia; Zhenzhen Ju; Ping Yuan; Siyang Fan; Qinmei Xiong; Bo Zhu; Lin Huang; Chunjiao You; Huihui Bao; Yanqing Wu; Xiaoshu Cheng; Juxiang Li; Ali J Marian; Kui Hong
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.